165 related articles for article (PubMed ID: 705690)
1. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
Clemmensen I
Thromb Haemost; 1978 Jun; 39(3):616-23. PubMed ID: 705690
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of urokinase by complex formation with human alpha1-antitrypsin.
Clemmensen I; Christensen F
Biochim Biophys Acta; 1976 Apr; 429(2):591-9. PubMed ID: 1083251
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
4. Purification and properties of guinea pig antithrombin III.
Heck L; Rosenberg R; Remold H
Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
[TBL] [Abstract][Full Text] [Related]
5. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
Marciniak E
Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
[TBL] [Abstract][Full Text] [Related]
6. Human articular cartilage contains an inhibitor of plasminogen activator.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin III Alger: a new homozygous AT III variant.
Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.
Stump DC; Thienpont M; Collen D
J Biol Chem; 1986 Sep; 261(27):12759-66. PubMed ID: 3091604
[TBL] [Abstract][Full Text] [Related]
9. [Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].
Shevelev AIa; Barshevskaia TN; Belogurov AA; Kratasiuk GA; Goriunova LE
Mol Biol (Mosk); 1986; 20(3):778-88. PubMed ID: 3088432
[TBL] [Abstract][Full Text] [Related]
10. The interaction of immobilized thrombin with human antithrombin III.
Marciniak E; Gora-Maslak G
Thromb Haemost; 1984 Feb; 51(1):27-31. PubMed ID: 6719385
[TBL] [Abstract][Full Text] [Related]
11. Homozygous variant of antithrombin III: AT III Fontainebleau.
Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ
Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of the "classical" antithrombin III deficiency.
Sas G; Petö I; Bánhegyi D; Blaskó G; Domján G
Thromb Haemost; 1980 Jun; 43(2):133-6. PubMed ID: 7455972
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional characterization of the inhibition of urokinase by alpha 2-macroglobulin.
Straight DL; Hassett MA; McKee PA
Biochemistry; 1985 Jul; 24(15):3902-7. PubMed ID: 2413880
[TBL] [Abstract][Full Text] [Related]
14. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
[TBL] [Abstract][Full Text] [Related]
15. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium.
Walker JE; Gow L; Campbell DM; Ogston D
Thromb Haemost; 1983 Feb; 49(1):21-3. PubMed ID: 6221434
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of tissue activator and urokinase by human plasma.
Walker JE; Ogston D
Thromb Haemost; 1982 Jun; 47(3):265-8. PubMed ID: 6180497
[TBL] [Abstract][Full Text] [Related]
17. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen-activator in human early milk: its partial purification and characterization.
Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA
Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3.
Stief TW; Radtke KP; Heimburger N
Biol Chem Hoppe Seyler; 1987 Oct; 368(10):1427-33. PubMed ID: 3501295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
